XRF Scientific (XRF.AX) Stock Price
XRF Scientific Price
Revenue has compounded at 12.8% per year over the past 19 years to 59.45 M AUD. Earnings per share have grown at 8.3% per year over the last 19 years. XRF Scientific's net margin stands at 17.5%, up from 16.4% several years earlier. XRF Scientific currently offers a dividend yield of about 3.45%. The payout ratio is around 87% of earnings. The dividend has grown at 13.8% per year over the past 17 years. Analysts set a median price target of 2.40 AUD, implying 28.5% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus. The stock trades about 15% above its 52-week low.
XRF Scientific stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of XRF Scientific over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how XRF Scientific stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing XRF Scientific's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | XRF Scientific Price |
|---|---|
| 9/4/2026 | 1.87 AUD |
| 9/3/2026 | 1.84 AUD |
| 9/2/2026 | 1.83 AUD |
| 9/1/2026 | 1.84 AUD |
| 8/31/2026 | 1.80 AUD |
| 8/28/2026 | 1.83 AUD |
| 8/27/2026 | 1.83 AUD |
| 8/26/2026 | 1.82 AUD |
| 8/25/2026 | 1.84 AUD |
| 8/24/2026 | 1.86 AUD |
| 8/21/2026 | 1.87 AUD |
| 8/20/2026 | 1.88 AUD |
| 8/19/2026 | 1.86 AUD |
| 8/18/2026 | 1.88 AUD |
| 8/17/2026 | 1.90 AUD |
| 8/14/2026 | 1.86 AUD |
| 8/13/2026 | 1.83 AUD |
| 8/12/2026 | 1.80 AUD |
| 8/11/2026 | 1.88 AUD |
| 8/10/2026 | 1.82 AUD |
| 8/7/2026 | 1.83 AUD |
| 8/6/2026 | 1.79 AUD |
| 8/5/2026 | 1.73 AUD |
| 8/4/2026 | 1.71 AUD |
| 8/3/2026 | 1.74 AUD |
| 7/31/2026 | 1.75 AUD |
| 7/30/2026 | 1.70 AUD |
| 7/29/2026 | 1.68 AUD |
| 7/28/2026 | 1.68 AUD |
| 7/27/2026 | 1.71 AUD |
XRF Scientific Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
XRF Scientific Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM AUD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM AUD |
| EBITM AUD |
| EBIT MARGIN% |
| NET INCOMEM AUD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.AUD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.00 | 20.00 | 21.00 | 21.00 | 24.00 | 29.00 | 29.00 | 31.00 | 40.00 | 55.00 | 60.00 | 59.00 | 64.00 | 72.00 | 80.00 | 91.00 |
| -4.55 | -4.76 | 5.00 | – | 14.29 | 20.83 | – | 6.90 | 29.03 | 37.50 | 9.09 | -1.67 | 8.47 | 12.50 | 11.11 | 13.75 |
| 38.10 | 40.00 | 38.10 | 38.10 | 37.50 | 37.93 | 41.38 | 41.94 | 42.50 | 40.00 | 43.33 | 47.46 | 47.46 | 47.46 | 47.46 | 47.46 |
| 8.00 | 8.00 | 8.00 | 8.00 | 9.00 | 11.00 | 12.00 | 13.00 | 17.00 | 22.00 | 26.00 | 28.00 | 30.37 | 34.17 | 37.97 | 43.19 |
| 3.00 | 3.00 | 2.00 | 1.00 | 1.00 | 3.00 | 4.00 | 5.00 | 8.00 | 11.00 | 13.00 | 14.00 | 16.00 | 18.00 | 20.00 | 23.00 |
| 14.29 | 15.00 | 9.52 | 4.76 | 4.17 | 10.34 | 13.79 | 16.13 | 20.00 | 20.00 | 21.67 | 23.73 | 25.00 | 25.00 | 25.00 | 25.27 |
| 2.00 | 2.00 | 1.00 | – | 1.00 | 2.00 | 3.00 | 5.00 | 6.00 | 7.00 | 8.00 | 10.00 | 11.00 | 12.00 | 14.00 | 16.00 |
| -33.33 | – | -50.00 | – | – | 100.00 | 50.00 | 66.67 | 20.00 | 16.67 | 14.29 | 25.00 | 10.00 | 9.09 | 16.67 | 14.29 |
| 0.05 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | 0.05 | 0.06 | 0.06 | 0.06 | 0.08 | 0.09 | – |
| 25.00 | -60.00 | -50.00 | – | – | – | 100.00 | 50.00 | – | 66.67 | 20.00 | – | – | 33.33 | 12.50 | – |
| 132.16 | 132.16 | 133.13 | 133.83 | 133.83 | 133.83 | 133.83 | 134.35 | 135.47 | 136.69 | 137.78 | 140.15 | 140.15 | 140.15 | 140.15 | 140.15 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales XRF Scientific generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue XRF Scientific retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare XRF Scientific's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares XRF Scientific has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against XRF Scientific's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
XRF Scientific stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
XRF Scientific Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
XRF Scientific business model & stock analysis
XRF Scientific Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
XRF Scientific historical P/E ratio, EBIT multiple, and P/S ratio
XRF Scientific annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
XRF Scientific shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
XRF Scientific Dividend History
18 years of dividend payments · 8 consecutive increases
XRF Scientific dividend history and estimates
Max
Details
XRF Scientific dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current XRF Scientific forecasts and price targets in September 2026
Analyst Price Targets 2026XRF Scientific shareholder structure
| % | Name |
|---|---|
0.82015% | |
0.59445% | |
0.58115% | |
0.11355% | |
0.03287% | |
0.01758% |
XRF Scientific Beneficial Ownership Filings (SEC 13D/G)
XRF Scientific Executives and Management Board
5 members · avg. age 65 · 0 % women
Mr. Vance Stazzonelli
Managing Director, Executive Director, Joint Company Secretary · since 2008
774,385.00 AUD
Management
Mr. Andrew Watson
Chief Financial Officer, Joint Company Secretary
Board of Directors
Mr. David Brown
Non-Executive Director · since 2004
Mr. Frederick Grimwade (65)
Non-Executive Chairman of the Board
Mr. David Kiggins
Non-Executive Independent Director
Frequently asked questions about XRF Scientific
Analysts currently set an average price target of 2.40 AUD for the XRF Scientific stock (median: 2.40 AUD), implying +28.5 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the XRF Scientific stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect XRF Scientific to generate revenue of 64.75 M AUD and earnings per share of 0.08 AUD.
Converted at the current exchange rate, the XRF Scientific share trades at 1.16 EUR (1.87 AUD).
The XRF Scientific share (XRF.AX) is listed on 1 stock exchanges, including: ASX (XRF.AX).
No history available for XRF Scientific.
The expected revenue of XRF Scientific is 64.75 M AUD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of XRF Scientific is 11.44 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of XRF Scientific is currently 22.85. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the XRF Scientific stock.
The price-to-sales ratio (P/S) of XRF Scientific is currently 4.04. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the XRF Scientific stock.
The Eulerpool Quality Score for XRF Scientific is 7/10.
The ISIN of XRF Scientific is AU000000XRF8. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of XRF Scientific is XRF.AX. The ticker symbol is used to trade XRF Scientific shares on the stock exchange.
Over the past 12 months, XRF Scientific paid a dividend of 0.06 AUD . This corresponds to a dividend yield of about 3.45 %. For the coming 12 months, XRF Scientific is expected to pay a dividend of 0.08 AUD.
The current dividend yield of XRF Scientific is 3.45 %.
XRF Scientific pays a dividend, distributed in the months of , , , .
XRF Scientific paid dividends every year for the past 15 years.
For the upcoming 12 months, dividends amounting to 0.08 AUD are expected. This corresponds to a dividend yield of 4.14 %.
XRF Scientific is assigned to the 'Industry' sector.
To receive the latest dividend of XRF Scientific from amounting to 0.06 AUD, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
In the year 2025, XRF Scientific distributed 0.05 AUD as dividends.
The dividends of XRF Scientific are distributed in AUD.
XRF Scientific stock
XRF Scientific Peer Group
XRF Scientific Ticker
XRF Scientific FIGI
All fundamentals and in-depth analysis of XRF Scientific
Our stock analysis for XRF Scientific stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of XRF Scientific. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.